Avantium Valuation

Is 0RNP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0RNP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 0RNP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 0RNP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0RNP?

Key metric: As 0RNP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0RNP. This is calculated by dividing 0RNP's market cap by their current revenue.
What is 0RNP's PS Ratio?
PS Ratio	8.1x
Sales	€21.40m
Market Cap	€172.50m

0RNP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	11.7x
Enterprise Value/EBITDA	-8.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 0RNP's PS Ratio compare to its peers?

The above table shows the PS ratio for 0RNP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.4x
BEG Begbies Traynor Group	1.1x	6.3%	UK£146.7m
PPHC Public Policy Holding Company	1.4x	9.6%	UK£158.5m
GTLY Gateley (Holdings)	1x	5.2%	UK£176.3m
KEYS Keystone Law Group	2.2x	5.3%	UK£199.0m
0RNP Avantium	8.1x	56.0%	€172.5m

Price-To-Sales vs Peers: 0RNP is expensive based on its Price-To-Sales Ratio (8.1x) compared to the peer average (1.4x).

Price to Sales Ratio vs Industry

How does 0RNP's PS Ratio compare vs other companies in the GB Professional Services Industry?

10 Companies	Price / Sales	Estimated Growth	Market Cap
HAS Hays	0.2x	1.0%	US$1.57b
IPEL Impellam Group	0.2x	n/a	US$489.91m
CPI Capita	0.1x	1.3%	US$360.03m
RWA Robert Walters	0.2x	0.02%	US$287.36m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 0RNP is expensive based on its Price-To-Sales Ratio (8.1x) compared to the UK Professional Services industry average (0.7x).

Price to Sales Ratio vs Fair Ratio

What is 0RNP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0RNP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	8.1x
Fair PS Ratio	0.3x

Price-To-Sales vs Fair Ratio: 0RNP is expensive based on its Price-To-Sales Ratio (8.1x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0RNP forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€2.18	€5.21 +139.7%	48.8%	€9.57	€1.90	n/a	5
Nov ’25	€2.33	€5.21 +123.8%	48.8%	€9.57	€1.90	n/a	5
Oct ’25	€1.89	€5.41 +187.1%	48.7%	€9.57	€1.90	n/a	5
Sep ’25	€1.89	€5.41 +187.1%	48.7%	€9.57	€1.90	n/a	5
Aug ’25	€2.48	€5.63 +127.6%	42.0%	€9.57	€3.00	n/a	5
Jul ’25	€2.59	€5.63 +117.5%	42.0%	€9.57	€3.00	n/a	5
Jun ’25	€2.60	€5.63 +117.1%	42.0%	€9.57	€3.00	n/a	5
May ’25	€2.56	€5.63 +120.1%	42.0%	€9.57	€3.00	n/a	5
Apr ’25	€2.11	€5.63 +167.0%	42.0%	€9.57	€3.00	n/a	5
Mar ’25	€2.16	€5.81 +169.2%	37.6%	€9.57	€3.90	n/a	5
Feb ’25	€2.46	€6.27 +154.8%	35.5%	€9.57	€3.90	n/a	4
Jan ’25	€3.52	€6.27 +77.8%	35.5%	€9.57	€3.90	n/a	4
Dec ’24	€4.25	€6.67 +57.0%	38.9%	€10.00	€3.90	n/a	5
Nov ’24	€3.20	€6.67 +108.9%	38.9%	€10.00	€3.90	€2.33	5
Oct ’24	€3.27	€6.67 +104.1%	38.9%	€10.00	€3.90	€1.89	5
Sep ’24	€3.44	€6.95 +102.0%	42.3%	€10.95	€3.90	€1.89	5
Aug ’24	€3.46	€7.39 +113.5%	42.2%	€10.95	€3.90	€2.48	4
Jul ’24	€3.74	€7.39 +97.5%	42.2%	€10.95	€3.90	€2.59	4
Jun ’24	€3.58	€7.39 +106.3%	42.2%	€10.95	€3.90	€2.60	4
May ’24	€3.58	€7.64 +113.4%	37.6%	€10.95	€4.40	€2.56	4
Apr ’24	€3.63	€7.64 +110.2%	37.6%	€10.95	€4.40	€2.11	4
Mar ’24	€4.52	€7.64 +69.0%	37.6%	€10.95	€4.40	€2.16	4
Feb ’24	€4.68	€8.45 +80.6%	34.2%	€10.95	€4.40	€2.46	3
Jan ’24	€3.69	€8.45 +129.0%	34.2%	€10.95	€4.40	€3.52	3
Dec ’23	€3.72	€8.45 +127.2%	34.2%	€10.95	€4.40	€4.25	3
Nov ’23	€3.30	€7.64 +131.4%	37.6%	€10.95	€4.40	€3.20	4

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.